Eli Lilly goes direct-to-consumer on weight loss drugs: What patients and investors need to know [YE3Mt6sdJ2g]
| 1h 28m 28s | Video has closed captioning.
Michael Yee, Jefferies senior biotech analyst, joins 'Squawk Box' to discuss news of Eli Lilly's launch of 'LillyDirect', an online direct-to-consumer pharmacy where patients can get the company's obesity, diabetes and migraine medications sent to their home with a doctor's prescription, the impact on patients and investors, and more.
Aired: December 12, 2024
Buy Now:
Eli Lilly goes direct-to-consumer on weight loss drugs: What patients and investors need to know [YE3Mt6sdJ2g]
Fixed iFrame
Responsive iFrame
Problems Playing Video? | Closed Captioning
